Clinical trial
Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations
NCT04296604 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 30, 2014
- Completion date
- April 30, 2026
- Enrollment
- 600 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
attention deficit hyperactivity disorder, bipolar disorder, borderline personality disorder, major depressive disorder, schizophrenia, substance use disorders, traumatic brain injury